FABP1 and liver dysplastic nodule: Urinary L-FABP levels were significantly higher in diabetic patients with nephropathy than in healthy subjects and correlated positively with urinary albumin, UACR, and albuminuria and inversely with GFR, indicating its possible clinical application as a complementary marker of DN [47–49].